Corps Capital Advisors LLC Makes New Investment in CVS Health Co. (NYSE:CVS)

Corps Capital Advisors LLC bought a new position in shares of CVS Health Co. (NYSE:CVS) in the 4th quarter, HoldingsChannel.com reports. The fund bought 5,329 shares of the pharmacy operator’s stock, valued at approximately $239,000.

Several other institutional investors have also recently bought and sold shares of CVS. AMF Tjanstepension AB increased its stake in shares of CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock valued at $3,882,000 after buying an additional 34,198 shares during the period. Sequoia Financial Advisors LLC increased its stake in shares of CVS Health by 49.2% in the third quarter. Sequoia Financial Advisors LLC now owns 47,708 shares of the pharmacy operator’s stock valued at $3,000,000 after buying an additional 15,741 shares during the period. Waldron Private Wealth LLC increased its stake in shares of CVS Health by 9.7% in the third quarter. Waldron Private Wealth LLC now owns 7,005 shares of the pharmacy operator’s stock valued at $440,000 after buying an additional 622 shares during the period. Community Trust & Investment Co. increased its stake in shares of CVS Health by 2.2% in the third quarter. Community Trust & Investment Co. now owns 259,457 shares of the pharmacy operator’s stock valued at $16,315,000 after buying an additional 5,643 shares during the period. Finally, Albert D Mason Inc. increased its stake in shares of CVS Health by 1.5% in the third quarter. Albert D Mason Inc. now owns 15,425 shares of the pharmacy operator’s stock valued at $970,000 after buying an additional 224 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on CVS shares. Edward Jones raised CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Cantor Fitzgerald upgraded CVS Health from a “neutral” rating to an “overweight” rating in a report on Wednesday, February 12th. Leerink Partnrs upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 12th. Barclays upped their target price on CVS Health from $71.00 to $73.00 and gave the company an “overweight” rating in a report on Thursday, February 13th. Finally, Evercore ISI upped their target price on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a report on Monday, January 27th. Four research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $70.00.

Insider Activity at CVS Health

In related news, Director Michael F. Mahoney purchased 30,000 shares of the stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the transaction, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.24% of the stock is currently owned by insiders.

CVS Health Price Performance

Shares of CVS opened at $66.35 on Thursday. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $80.75. The business’s fifty day moving average is $51.80 and its 200 day moving average is $56.12. The company has a quick ratio of 0.60, a current ratio of 0.81 and a debt-to-equity ratio of 0.80. The stock has a market cap of $83.65 billion, a P/E ratio of 18.13, a P/E/G ratio of 0.98 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. Sell-side analysts anticipate that CVS Health Co. will post 5.92 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Investors of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.01%. The ex-dividend date was Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.